The general findings of several randomized controlled trials (RCTs) and systematic reviews suggest that metformin is an effective means of controlling blood sugar levels and may reduce the need for insulin therapy in women with GDM, particularly in those who are overweight or obese. Here, INS is linked to gestational diabetes.